VAL-0620

N/A

Report date: 2024/12/17 14:16:29

Base Information

Drug NameVAL-0620
Drug Alias NameVAL-0620
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionMyotubularin replacement
TargetsMyotubularin
Therapy Area/IndicationsMuscular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValerion Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValerion Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsMuscular Diseases

Other Information

ATC CodeN/A
Related LinksN/A